Sionna Therapeutics, Inc. (SION) Dividend History

Sionna Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies targeting cell signaling pathways involved in oncology and other diseases. Leveraging advanced scientific research, the company aims to create novel treatments that address unmet medical needs in cancer and related conditions.

Dividend History

Sionna Therapeutics, Inc. currently does not pay dividends

Company News

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Sionna Therapeutics, a clinical-stage biopharmaceutical company, announced the closing of its upsized initial public offering, raising $219.2 million. The company is developing novel medicines to treat cystic fibrosis by normalizing the function of the CFTR protein.

Benzinga

Page data last updated 08/19/2025 16:56:32 UTC